Finzati - Logo
ACB logo

Aurora Cannabis Inc.

ACB • Drug Manufacturers - Specialty & Generic
$3.95
— 0.00 (0.00%)
EarningsLatest report: Mar 31, 2026
HIGHER-RISK PROFILECautionConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$227.01M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.05Healthy liquidity · 5.94Negative growth trendWeak profitability
Financial data as of: Mar 31, 2026, 12:00 AM UTCLast earnings update: Jun 11, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$3.95
Change0.00%
Shares Out57.47M
Market Cap$227.01M
52W Range2.56 - 6.67
Beta1.34
P/E-2.96
P/S1.13
P/B0.70
P/FCF-10.02
EV/Sales0.53
EV/EBITDA-4.18

Investment DNA

How strong this company looks for long-term investors

43
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
95/100
Why this score▼
Manageable debt level · 0.05Healthy liquidity · 5.94Negative growth trendWeak profitability

Analyst view

Analyst sentiment and price target

ACB
Analyst sentiment
Based on 14 analyst votes · 2026-09-05
50/100
Neutral
Bullish
3
Hold
8
Bearish
3
Price Target
2026-08-05
Low
$1.00
Mean
$5.92
Median
$8.00
High
$8.75

Company Overview

IPO: 7/15/2014
Industry: Drug Manufacturers - Specialty & Generic
P/B i: 0.70
Debt / Equity i: 0.05
Operating Margin: -14.55%
Net Margin: -42.41%
ROE i: -
ROIC: -

Financial Health

Score15 / 20
Debt / Equity: 0.05
Current Ratio: 5.94
Quick Ratio: 3.32
Status: Good
🧾

No insider activity

No recent insider transactions available.